balakotu
★    

India,
2012-04-02 17:06
(5182 d 19:30 ago)

Posting: # 8365
Views: 5,910
 

 power calculation for partial /full replicate study designs [Regulatives / Guidelines]

Dear All,

How to calculate Power in Partial/fully replicate study design based on FDA's Progesterone guidance SAS Program. Whether power is required are not in replicate study designs.

Regards
Kotu.
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-04-02 18:19
(5182 d 18:17 ago)

@ balakotu
Posting: # 8367
Views: 5,211
 

 Useless power

Dear Kotu!

❝ How to calculate Power in Partial/fully replicate study design based on FDA's Progesterone guidance SAS Program. Whether power is required are not in replicate study designs.


Power is not mentioned anywhere in the code with good reasons. Retrospective (aka a posteriori, post-hoc) power calculations are futile in bioequivalence studies (of any design). Either the study passed or not.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
balakotu
★    

India,
2012-04-17 08:11
(5168 d 04:24 ago)

@ Helmut
Posting: # 8424
Views: 4,940
 

 Useless power

Dear Vienna,

you said

❝ power calculations are futile in bioequivalence studies (of any design). Either the study passed or not.


some time based on less power we are conduction two stage appraoch. but you said power calculations are futile why?


Regards
Kotu.
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-04-25 18:32
(5159 d 18:03 ago)

@ balakotu
Posting: # 8462
Views: 4,976
 

 Useless power: over & over again

Dear Mumbai! :-D

❝ Dear Vienna,

    ↑↑↑↑↑↑↑↑↑


❝ some time based on less power we are conduction two stage appraoch. but you said power calculations are futile why?


Two Stage studies can help in dealing with uncertain CVs – e.g., if you have only data from literature, old studies, or small pilot studies. The power calculation in the interim analysis is part of the decision tree; no post-hoc power calculation should be performed. What I said about conventional BE studies is applicable here as well: Either the study passed or not.
See also Potvin et al. (2008), Example 2, Method B:

[…] we obtain a two-sided CI for the ratio (T/R) of geometric means of 88.45—116.38%, which meets the 80—125% acceptance criterion. We stop here and conclude BE, irrespective of the fact that we have not yet achieved the desired power of 80% (power = 66.3%).

(my emphasis)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
lindseyk
●    

2012-04-27 18:25
(5157 d 18:10 ago)

@ Helmut
Posting: # 8468
Views: 4,805
 

 Useless power: over & over again

Hello,
Could post-hoc power analyses help in a pilot study with two test formulations compared to 1 reference in deciding which formulation to go forward with in a pivotal study?


Edit: Full quote removed. Please delete anything from the text of the original poster which is not necessary in understanding your answer; see also this post! [Ohlbe]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-04-28 05:12
(5157 d 07:23 ago)

@ lindseyk
Posting: # 8469
Views: 4,833
 

 What for?

Hi Lindsay!

❝ Could post-hoc power analyses help in a pilot study with two test formulations compared to 1 reference in deciding which formulation to go forward with in a pivotal study?


No – what would you expect to gain? In any higher-order Xover (e.g., 3×3 Latin Squares, 6×3 Williams’ design) you get only a common estimate of the intra-subject variance. So it boils down to assessing the point estimates T1/R and T2/R. Select the one closer to 100%. Theoretically [sic] you could run a replicate design to assess the intra-subject variances of formulations as well. If the test/reference ratios are similar (or one is the reciprocal of the other) you could select the one with lower variability. But with two tests you will end up with a f**ing complicated replicate design with many periods, even if you a apply a modified Balaam’s design. Haven’t seen any such a study in 30+ years… ;-)

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,653 posts in 4,991 threads, 1,570 registered users;
222 visitors (0 registered, 222 guests [including 17 identified bots]).
Forum time: 12:36 CEST (Europe/Vienna)

There are no dangerous thoughts;
thinking itself is dangerous.    Hannah Arendt

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5